• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    AdaptHealth Corp. Announces Third Quarter 2023 Earnings Release Date and Conference Call

    10/17/23 4:05:00 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care
    Get the next $AHCO alert in real time by email

    AdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its third quarter 2023 financial results before the opening of the financial markets on Tuesday, November 7, 2023. Management will host a teleconference at 8:30 a.m. ET to discuss the results and business activities with analysts and investors.

    Interested parties may participate in the call by dialing:

    • (800) 245-3047 (Domestic) or
    • (203) 518-9765 (International)

    When prompted, reference Conference ID: AHCO3Q23

    Webcast registration: Click Here

    Following the live call, a replay will be available for six months on the Company's website, www.adapthealth.com under "Investor Relations."

    About AdaptHealth Corp.

    AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home, adapt to challenges in their activities of daily living, and thrive. Product and service offerings include (i) sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) HME to patients discharged from acute care and other facilities, (iv) oxygen and related chronic therapy services in the home, and (v) other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors, reaching approximately 3.9 million patients annually in all 50 states through its network of approximately 725 locations in 47 states.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231017002915/en/

    Get the next $AHCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AHCO

    DatePrice TargetRatingAnalyst
    1/8/2024$14.50 → $8.00Buy → Hold
    Jefferies
    11/8/2023$9.50 → $6.50Neutral → Underperform
    BofA Securities
    5/10/2023$28.00 → $11.30Buy → Hold
    Deutsche Bank
    5/10/2023$18.00 → $11.00Buy → Hold
    Stifel
    5/9/2023$21.00 → $12.00Buy → Neutral
    BofA Securities
    3/8/2022$31.00 → $26.00Outperform
    RBC Capital
    3/2/2022$32.00 → $24.00Outperform
    SVB Leerink
    2/18/2022$35.00 → $32.00Outperform
    SVB Leerink
    More analyst ratings

    $AHCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AdaptHealth downgraded by Jefferies with a new price target

      Jefferies downgraded AdaptHealth from Buy to Hold and set a new price target of $8.00 from $14.50 previously

      1/8/24 9:03:40 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth downgraded by BofA Securities with a new price target

      BofA Securities downgraded AdaptHealth from Neutral to Underperform and set a new price target of $6.50 from $9.50 previously

      11/8/23 6:22:25 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care
    • AdaptHealth downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded AdaptHealth from Buy to Hold and set a new price target of $11.30 from $28.00 previously

      5/10/23 6:33:54 AM ET
      $AHCO
      Medical/Nursing Services
      Health Care